86 related articles for article (PubMed ID: 30819007)
1. KHC-4 inhibits β-catenin expression in prostate cancer cells.
Huang CY; Velmurugan BK; Chen MC; Day CH; Chien WS; Padma VV; Wu HC; Lin TH; Hsu HH; Shen CH
Biotech Histochem; 2019 Jul; 94(5):374-380. PubMed ID: 30819007
[TBL] [Abstract][Full Text] [Related]
2. Mitotic arrest induced in human DU145 prostate cancer cells in response to KHC-4 treatment.
Shen CH; Lin TH; Hsieh YL; Shen CY; Kuo SC; Wu HC; Chien WS; Hsieh DJ; Wen SY; Ting WJ; Yao CH; Huang CY
Environ Toxicol; 2016 Dec; 31(12):1879-1887. PubMed ID: 26305502
[TBL] [Abstract][Full Text] [Related]
3. KHC-4 anti-cancer effects on human PC3 prostate cancer cell line.
Hwang JM; Ting WJ; Wu HC; Chen YJ; Tsai FJ; Chen PY; Liu CY; Chou LC; Kuo SC; Huang CY
Am J Chin Med; 2012; 40(5):1063-71. PubMed ID: 22928835
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in human DU145 prostate cancer cells by KHC-4 treatment.
Lin TH; Chen WC; Wu HC; Chien WS; Lee SS; Tsai FJ; Tsai CH; Ting WJ; Kuo SC; Huang CY
Chin J Physiol; 2014 Apr; 57(2):99-104. PubMed ID: 24694199
[TBL] [Abstract][Full Text] [Related]
5. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
Zhao L; Miao HC; Li WJ; Sun Y; Huang SL; Li ZY; Guo QL
Mol Carcinog; 2016 May; 55(5):778-92. PubMed ID: 25945460
[TBL] [Abstract][Full Text] [Related]
6. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
7. CWF-145, a novel synthetic quinolone derivative exerts potent antimitotic activity against human prostate cancer: Rapamycin enhances antimitotic drug-induced apoptosis through the inhibition of Akt/mTOR pathway.
Hung CM; Lin YC; Liu LC; Kuo SC; Ho CT; Way TD
Chem Biol Interact; 2016 Dec; 260():1-12. PubMed ID: 27769712
[TBL] [Abstract][Full Text] [Related]
8. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
[TBL] [Abstract][Full Text] [Related]
9. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation.
Lu W; Tinsley HN; Keeton A; Qu Z; Piazza GA; Li Y
Eur J Pharmacol; 2009 Jan; 602(1):8-14. PubMed ID: 19026633
[TBL] [Abstract][Full Text] [Related]
11. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.
Thamilselvan V; Menon M; Thamilselvan S
Int J Cancer; 2011 Dec; 129(12):2916-27. PubMed ID: 21472727
[TBL] [Abstract][Full Text] [Related]
12. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
Park N; Baek HS; Chun YJ
PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
[TBL] [Abstract][Full Text] [Related]
13. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
14. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.
Sun P; Xiong H; Kim TH; Ren B; Zhang Z
Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitously expressed hematological and neurological expressed 1 downregulates Akt-mediated GSK3β signaling, and its knockdown results in deregulated G2/M transition in prostate cells.
Varisli L; Gonen-Korkmaz C; Debelec-Butuner B; Erbaykent-Tepedelen B; Muhammed HS; Bogurcu N; Saatcioglu F; Korkmaz KS
DNA Cell Biol; 2011 Jun; 30(6):419-29. PubMed ID: 21323578
[TBL] [Abstract][Full Text] [Related]
16. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
17. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
18. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
[TBL] [Abstract][Full Text] [Related]
19. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells.
Park JH; Kwon HY; Sohn EJ; Kim KA; Kim B; Jeong SJ; Song JH; Koo JS; Kim SH
Pharmacol Rep; 2013; 65(5):1366-74. PubMed ID: 24399733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
